Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al.
Kristin M D'SilvaNaomi Serling-BoydRachel WallworkTiffany HsuJeffrey A SparksZachary Scott WallacePublished in: Annals of the rheumatic diseases (2020)